Phase III Clinical Trials in Alzheimer's Disease

TRx0237 Phase III Clinical Trials in Alzheimer's Disease https://clinicaltrials.gov/study/NCT01689246 TauRx Pharmaceuticals conducted phase III studies of TRx0237, a methylene blue derivative with ...